54 related articles for article (PubMed ID: 22935974)
21. Long-term regulation of signalling components of adenylyl cyclase and mitogen-activated protein kinase in the pre-frontal cortex of human opiate addicts.
Ferrer-Alcón M; García-Fuster MJ; La Harpe R; García-Sevilla JA
J Neurochem; 2004 Jul; 90(1):220-30. PubMed ID: 15198681
[TBL] [Abstract][Full Text] [Related]
22. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
[TBL] [Abstract][Full Text] [Related]
23. Mek1/2 MAPK kinases are essential for Mammalian development, homeostasis, and Raf-induced hyperplasia.
Scholl FA; Dumesic PA; Barragan DI; Harada K; Bissonauth V; Charron J; Khavari PA
Dev Cell; 2007 Apr; 12(4):615-29. PubMed ID: 17419998
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of ecotropic viral integration site 2A indicates a poor prognosis and promotes osteosarcoma evolution through activating MEK/ERK pathway.
Li S; Yang F; Yang YK; Zhou Y
J Recept Signal Transduct Res; 2019 Aug; 39(4):368-372. PubMed ID: 31774019
[TBL] [Abstract][Full Text] [Related]
25. Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma.
Liu JF; Chen PC; Chang TM; Hou CH
J Exp Clin Cancer Res; 2020 Nov; 39(1):254. PubMed ID: 33228783
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of phosphatidylethanolamine binding protein 1 associates with clinical risk factors in gastrointestinal stromal tumors, but not with activation of the RAF-1-MEK-ETV1 pathway.
Schoppmann SF; Beer A; Nirtl N; Ba-Ssalamah A; Brodowicz T; Streubel B; Birner P
Cancer Lett; 2013 Jul; 335(1):26-30. PubMed ID: 23376254
[TBL] [Abstract][Full Text] [Related]
27. Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma.
Abdeen A; Chou AJ; Healey JH; Khanna C; Osborne TS; Hewitt SM; Kim M; Wang D; Moody K; Gorlick R
Cancer; 2009 Nov; 115(22):5243-50. PubMed ID: 19670450
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma.
Hao H; Chen L; Huang D; Ge J; Qiu Y; Hao L
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27349943
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of the phosphorylation of MAPK and protein expression of cyclin D1 in human osteosarcoma tissues.
Wu J; Cui LL; Yuan J; Wang Y; Song S
Mol Med Rep; 2017 Apr; 15(4):2303-2307. PubMed ID: 28260005
[TBL] [Abstract][Full Text] [Related]
30. Expression of the interleukin-21 and phosphorylated extracellular signal regulated kinase 1/2 in Kimura disease.
Chen QL; Li CX; Shao B; Gong ZC; Liu H; Ling B; Abasi K; Hu LL; Wang B; Yin XP
J Clin Pathol; 2017 Aug; 70(8):684-689. PubMed ID: 28108473
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer.
Mukherjee R; McGuinness DH; McCall P; Underwood MA; Seywright M; Orange C; Edwards J
Br J Cancer; 2011 Jun; 104(12):1920-8. PubMed ID: 21559022
[TBL] [Abstract][Full Text] [Related]
32. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario.
Candido MF; Medeiros M; Veronez LC; Bastos D; Oliveira KL; Pezuk JA; Valera ET; Brassesco MS
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839989
[TBL] [Abstract][Full Text] [Related]
33. Chlorogenic Acid Enhances Doxorubicin-Mediated Cytotoxic Effect in Osteosarcoma Cells.
Salzillo A; Ragone A; Spina A; Naviglio S; Sapio L
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445291
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k‑Ras/Raf/MEK/ERK signaling pathway.
Guo L; Bai Y; Ji S; Ma H
Int J Oncol; 2019 Mar; 54(3):807-820. PubMed ID: 30664191
[TBL] [Abstract][Full Text] [Related]
35. [ARTICLE WITHDRAWN] Dexmedetomidine Inhibits Osteosarcoma Cell Proliferation and Migration, and Promotes Apoptosis by Regulating miR-520a-3p.
Wang X; Xu Y; Chen X; Xiao J
Oncol Res; 2018 Apr; 26(3):495-502. PubMed ID: 28653601
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of PARP-1 Inhibits Proliferation and ERK Signals, Increasing Drug Sensitivity in Osteosarcoma U2OS Cells.
Li S; Cui Z; Meng X
Oncol Res; 2016; 24(4):279-86. PubMed ID: 27656839
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs and Potential Targets in Osteosarcoma: Review.
Sampson VB; Yoo S; Kumar A; Vetter NS; Kolb EA
Front Pediatr; 2015; 3():69. PubMed ID: 26380245
[TBL] [Abstract][Full Text] [Related]
38. Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules.
Poos K; Smida J; Maugg D; Eckstein G; Baumhoer D; Nathrath M; Korsching E
PLoS One; 2015; 10(4):e0123082. PubMed ID: 25848766
[TBL] [Abstract][Full Text] [Related]
39. Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Kotta-Loizou I; Klijanienko J; Giaginis C; Alexandrou P; Dana E; Rodriguez J; Patsouris E; Sastre-Garau X
Tumour Biol; 2014 Jul; 35(7):6455-65. PubMed ID: 24682903
[TBL] [Abstract][Full Text] [Related]
40. Mitogen-activated protein kinase pathway in osteosarcoma.
Na KY; Kim YW; Park YK
Pathology; 2012 Oct; 44(6):540-6. PubMed ID: 22935974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
